Institut Catalá d'Oncologia, Hospital Duran i Reynals

Barcelona 8908

1 studies enrolling now · 8 studies all time

What they study most

Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Follicular Lymphoma (FL), GIST, Marginal Zone Lymphoma, Mast Cell Leukemia (MCL), Metastatic Colorectal Cancer, Myelodysplastic Syndrome, Non Hodgkin Lymphoma, Recurrent Platinum Resistant Ovarian Cancer

Studies at this site

• (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis — Recruiting now
• A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors — Recruiting now
• Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation — Completed
• A Clinical Trial Evaluating TG4050 in Head and Neck Cancer — Running, not enrolling
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early
• A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) — Completed
• (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST — Completed
• A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer — Stopped early